InsidersTradesSigma
Follow the 씨엑스아이 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 씨엑스아이 has logged 6 reports. Market capitalisation: €43.6bn. The latest transaction was reported on 17 June 2026 (Purchase). Among the most active insiders: LIN JINSHENG. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
씨엑스아이 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market.